Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 7/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.37 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.36 |
| ▸ | DRD2 | P14416 | 2/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | DRD4 | P21917 | 3/20 | 0.35 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | PLD2 | O14939 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21214284 | 0.97 | SLC6A5 (0.38) | CCR2CHRM4SLC6A5DRD2DRD3 | |
| SCHEMBL23936878 | 0.92 | CD274 (0.38) | CCR2CHRM4SLC6A5DRD2DRD3 | |
| Trifluoroacetic Acid SCHEMBL21196623 | 0.87 | CHRM2 (0.39) | CHRM4CHRM2CHRM1SLC6A5DRD4 | |
| Trifluoroacetic Acid SCHEMBL21196768 | 0.87 | CHRM2 (0.39) | CHRM4CHRM2CHRM1SLC6A5DRD4 | |
| SCHEMBL19745998 | 0.85 | SLC6A5 (0.37) | CCR2SLC6A5 | |
| SCHEMBL21214241 | 0.85 | RHOC (0.40) | CCR2SLC6A5DRD4HTR6EPHX2 | |
| Hydrochloric Acid SCHEMBL21196641 | 0.84 | RHOC (0.40) | CCR2SLC6A5DRD4HTR6 | |
| SCHEMBL21196583 | 0.81 | RHOC (0.37) | — | |
| SCHEMBL21196739 | 0.81 | GRIN2B (0.34) | CHRM4CHRM2CHRM1SLC6A5DRD2 | |
| SCHEMBL21214268 | 0.81 | GRIN2B (0.34) | CHRM4CHRM2CHRM1SLC6A5DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3475277-B1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | BIOIMICS AB (SE) | 2021-10-20 | — | — | EP | disclosed |